Comparison of CYFRA 21-1, CEA, CA 19-9 and CA 72-4 levels in gastric cancer

Comparison of CYFRA 21-1, CEA, CA 19-9 and CA 72-4 levels in gastric cancer

Objective: Gastric cancer is the fourth most common malignancy,and the second most common cause of cancermortality worldwide. The aim of this study was to investigatethe role of biomarkers CYFRA 21-1, CA 19-9, CEA,CA72.4 at diagnosis and throughout the follow-up in patientswith gastric cancer.Method...

Full description

Bibliographic Details
Main Authors:	Gökhan Çakırca, Cemal Polat, Ali İnal, Mehmet Küçüköner, Nuriye Mete, Fatma Birgül Işık
Format:	Article
Language:	English
Published:	Dicle University Medical School 2013-01-01
Series:	Dicle Medical Journal
Subjects:	Gastric cancer tumor markers CYFRA 21-1
Online Access:	http://www.diclemedj.org/upload/sayi/27/Dicle%20Med%20J-01631.pdf

Similar Items

Effect of oxaliplatin combined with capeeitabine as chemotherapy on serum CA125, CEA, TPS, Cyfra21-1, CA19-9 and T lymphocyte subsets of post-operative patients with advanced gastric carcinoma
by: Feng Deng, et al.
Published: (2016-08-01)

Avaliação dos valores sérico e pleural dos marcadores tumorais CEA, CYFRA21-1 e CA 15-3 em portadores de derrame pleural Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion
by: Isabella Coimbra Wagner, et al.
Published: (2007-04-01)

Value and significance of tumor markers as CEA, CA125, SCC-Ag, CA199 and CYFRA21-1 in the diagnosis of cervical cancer
by: Xiao-Juan Wang, et al.
Published: (2017-09-01)

Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125
by: Chunjing Jin, et al.
Published: (2019-11-01)

Correlation between Changes in Serum Level of CEA and CYFRA 21-1 and Objective Response of Chemotherapy
by: Xinlin MU, et al.
Published: (2009-09-01)

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
by: M. G. Dal Bello, et al.
Published: (2019-03-01)

Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients
by: Xinchun DUAN, et al.
Published: (2015-06-01)

Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
by: Chaiho Jeong, et al.
Published: (2021-02-01)

Diagnostic value of cyfra 21-1 and carcinoembryonic antigen in differentiation between benign and malignant pleural effusion
by: Waffa S. El-Shimy, et al.
Published: (2015-04-01)

Serum CYFRA 21-1 in Egyptian women with breast cancer
by: Samia A. Ebied, et al.
Published: (2017-03-01)

Usefulness of Circulating CYFRA21-1 in Patients as a Biomarker in Patients Taking Sorafenib or Lenvatinib for Unresectable Hepatocellular Carcinoma
by: Hitomi Takada, et al.
Published: (2021-08-01)

Comparison Study of Cyfra 21-1, Carcinoembryonic Antigen and Telomerase Activity between Non Small Cell and Small Cell Lung Cancer Patients
by: Behrang Alani, et al.
Published: (2008-12-01)

Diagnosis Value of the Detection of CYFRA21-1 in Non-small Cell Lung Cancer
by: Jundong GU, et al.
Published: (2010-12-01)

Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation
by: Preeti Singh, et al.
Published: (2017-01-01)

Diagnostic Significance of Combining Telomerase Activity with CYFRA21-1 Level in Differentiating Malignant Pleural Effusion Caused by Lung Cancer from Benign Pleural Effusio
by: Hongmei LI, et al.
Published: (2010-06-01)

Serum cytokeratin-19 fragment (Cyfra 21-1) is a prognostic indicator for epithelial ovarian cancer
by: Hua-Hsi Wu, et al.
Published: (2014-03-01)

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy
by: Mathieu Gauthé, et al.
Published: (2018-04-01)

Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors
by: Naghmeh Jeiroodi, et al.
Published: (2017-07-01)

Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma
by: Cao Xun, et al.
Published: (2012-09-01)

Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research
by: Fukuda, T., et al.
Published: (2022)

Effects of concurrent chemoradiotherapy on immune function and tumor markers SCC-Ag and CYFRA21-1 in patients with esophageal carcinoma
by: Ling-Li Jin, et al.
Published: (2017-08-01)

CYFRA 21-1 in Lymph Node Fine Needle Aspiration Washout Improves Diagnostic Accuracy for Metastatic Lymph Nodes of Differentiated Thyroid Cancer
by: Jeongmin Lee, et al.
Published: (2019-04-01)

Non-invasive bioassay of Cytokeratin Fragment 21.1 (Cyfra 21.1) protein in human saliva samples using immunoreaction method: An efficient platform for early-stage diagnosis of oral cancer based on biomedicine
by: Mohsen Jafari, et al.
Published: (2020-11-01)

Clinical Value of Abnormal Prothrombin Combined with CEA, CA72-4 and CA199 on Patients with Gastric Cancer
by: CAI Xiaojuan, et al.
Published: (2018-06-01)

Diagnostic Value of CYFRA 21-1 Measurement in Fine- Needle Aspiration Washouts for Detection of Axillary Recurrence in Postoperative Breast Cancer Patients
by: So Yeon Won, et al.
Published: (2020-01-01)

Effect of concurrent chemoradiotherapy with cisplatin and paclitaxel on immunological function and serum CYFRA21-1 and SCC-Ag in patients with middle and advanced cervical cancer
by: Wu-Song Tong, et al.
Published: (2016-12-01)

Evaluation of tumor markers carcinoembryonic antigen, cytokeratin 19 fragment and cancer-associated antigen 72-4 in neoplastic and non-neoplastic canine effusions differentiation
by: L.V. Teixeira, et al.
Published: (2014-10-01)

Clinical Value of Tumor Marker Index Based on Preoperative CYFRA 21-1 and SCC-Ag in the Evaluation of Prognosis and Treatment Effectiveness in Patients with Esophageal Squamous Cell Carcinoma
by: Yin N, et al.
Published: (2020-05-01)

Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer
by: Fan Feng, et al.
Published: (2017-11-01)

High-Sensitivity Detection of the Lung Cancer Biomarker CYFRA21-1 in Serum Samples Using a Carboxyl-MoS2 Functional Film for SPR-Based Immunosensors
by: Nan-Fu Chiu, et al.
Published: (2020-03-01)

Serum-based protein biomarkers for detection of lung cancer
by: Bhatnagar Shilpa, et al.
Published: (2014-04-01)

Standardization and performance evaluation of manual measurement method for paraoxonase activity
by: Gökhan Çakırca, et al.
Published: (2013-01-01)

Correlation between Serum Cytokeratin 19 Fragment and the Clinicopathological Features and Prognosis of Thymic Epithelial Tumors
by: Xuefei ZHANG, et al.
Published: (2018-07-01)

CA72-4 e CEA no soro e no lavado peritonial de doentes com câncer gástrico CA72-4 and CEA in serum and peritoneal washing in gastric cancer
by: Sandra MANDORWSKI, et al.
Published: (2002-03-01)

Clinical Significance and Prognostic Value of CA72-4 Compared with CEA and CA19-9 in Patients with Gastric Cancer
by: M. Ychou, et al.
Published: (2000-01-01)

Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients
by: Nikolaus A. Handke, et al.
Published: (2021-02-01)

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study
by: Lang D, et al.
Published: (2020-12-01)

Role of Serum Tumor Markers in Prognosis of Operable Non-small Cell Lung Cancer Patients
by: LI Shaolei, et al.
Published: (2018-01-01)

Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination
by: Chao Huang, et al.
Published: (2019-11-01)

Clinical Significance of CYFRA21-1, AFP, CA-153, CEA, and CA-199 in the Diagnosis of Lung Cancer Ocular Metastasis in Hypertension Population
by: Jing Tang, et al.
Published: (2021-09-01)